Gilead Sciences Again Named to Dow Jones Sustainability World Index

DJSI World highlights the most sustainable companies around the worldBased on the company’s sustainability assessment

– The rating reflects Gilead’s continued commitment to responsibility –

FOSTER CITY, Calif.–( BUSINESS WIRE )– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company has once again been recognized as one of the most sustainable pharmaceutical companies in the world by the Dow Jones Sustainability World Index (DJSI). The ranking is based on a comprehensive analysis of Gilead’s sustainability performance and highlights the company’s long-standing sustainable business practices and transparency on environmental, social and governance (ESG) issues.

“We are very pleased to once again receive this recognition, which reflects our commitment to patients, local communities, society and the planet,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences. “Corporate responsibility is integral to everything Gilead does as we pursue our vision to make the world a healthier place for all people.

Also Read :  Banksy unveils Ukraine mural in town bombed by Russia

Gilead’s ESG strategy aims to position the company as an employer of choice that responsibly delivers shareholder value. Examples of Gilead’s commitment to ESG include:

  • Increasing health equity worldwide through programs that promote health system sustainability, strengthen infrastructure, and provide education and financial support

  • Increasing access to medicines in low- and low-middle-income countries, including free voluntary licensing of Gilead’s antiviral treatment for COVID-19

  • Create an inclusive workplace that represents the diverse communities the company serves

  • Continue to develop the company’s environmental sustainability program and reduce greenhouse gas emissions, reduce waste generation and use resources efficiently

DJSI World uses a transparent, rules-based constituent selection process based on the companies’ S&P Global ESG score obtained from the annual S&P Global Corporate Sustainability Assessment (CSA). The CSA conducts a rigorous questionnaire that assesses public and non-public data provided by participating companies. This year, more than 10,000 publicly traded companies were invited to participate in the S&P Global CSA.

Details of Gilead’s ESG commitments, goals and progress can be found in the company’s Annual Review, which is based on internationally recognized guidelines from the Global Reporting Initiative, the Sustainability Accounting Standards Board, the Working Group on Climate-Related Financial Disclosures and the United Nations Sustainable Sector Guidelines. Development goals. Learn more about Gilead’s commitment to ESG and corporate responsibility at

About the Sciences of Gilead

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades to create a healthier world for all. The company is committed to developing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, inflammation and cancer. Gilead operates in more than 35 countries worldwide and is headquartered in Foster City, California.

Gilead and the Gilead logo are registered trademarks of Gilead Sciences, Inc. or trademarks of its affiliates.

For more information about Gilead, visit the company’s website at

follow Gilead on Twitter (@Gilead Sciences) or call Gilead Public Affairs at 1-800-
GILEAD-5 or 1-650-574-3000.

Jacquie Ross, Investors

[email protected]

Hayley Home, Media

[email protected]

Source: Gilead Sciences, Inc.


Also Read :  PGA Tour, DP World Tour bosses recuse themselves from LIV Golf's world ranking review

Leave a Reply

Your email address will not be published.

Related Articles

Back to top button